97 related articles for article (PubMed ID: 10955300)
21. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Moore NA; Blackman A; Awere S; Leander JD
Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
[TBL] [Abstract][Full Text] [Related]
22. [Ability of novel non-competitive glutamate receptor blocking agents to weaken motor disorders in animals].
Rukoiatkina NI; Gorbunova LV; Gmiro VE; Lukomskaia NIa
Ross Fiziol Zh Im I M Sechenova; 2001 Sep; 87(9):1260-7. PubMed ID: 11763540
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the blockade of glutamate channel receptors: significance for structural and physiological investigations.
Magazanik LG; Tikhonov DB; Tikhonova TB; Lukomskaya NY
Neurosci Behav Physiol; 2007 Mar; 37(3):277-84. PubMed ID: 17294104
[TBL] [Abstract][Full Text] [Related]
24. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
25. [Bis-ammonium adamantane derivatives--novel modulators of polyamine binding sites].
Gmiro VE; Serdiuk SE
Eksp Klin Farmakol; 2000; 63(3):16-20. PubMed ID: 10934589
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
27. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
Antonov SM; Johnson JW; Lukomskaya NY; Potapyeva NN; Gmiro VE; Magazanik LG
Mol Pharmacol; 1995 Mar; 47(3):558-67. PubMed ID: 7535380
[TBL] [Abstract][Full Text] [Related]
28. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.
Chartoff EH; Ward RP; Dorsa DM
J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068
[TBL] [Abstract][Full Text] [Related]
29. The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Zadow B; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):61-5. PubMed ID: 7908126
[TBL] [Abstract][Full Text] [Related]
30. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
[TBL] [Abstract][Full Text] [Related]
31. [Effects of ionotropic glutamate receptor channel blockers on the development of audiogenic seizures in Krushinski-Molodkina rats].
Lukomskaia NIa; Vataev SI; Zhabko EP; Magazanik LG
Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):449-60. PubMed ID: 22834334
[TBL] [Abstract][Full Text] [Related]
32. Two mechanisms of action of the adamantane derivative IEM-1460 at human AMPA-type glutamate receptors.
Schlesinger F; Tammena D; Krampfl K; Bufler J
Br J Pharmacol; 2005 Jul; 145(5):656-63. PubMed ID: 15834439
[TBL] [Abstract][Full Text] [Related]
33. [Effects of ionotropic glutamate receptor channel blockers ON sleep-waking organization in rats].
Vataev SI; Oganesian GA; Gmiro VE; Lukomskaia NIa; Magazanik LG
Ross Fiziol Zh Im I M Sechenova; 2012 Jul; 98(7):809-18. PubMed ID: 23074828
[TBL] [Abstract][Full Text] [Related]
34. [The action of ionotropic glutamate receptor channel blockers on effects of sleep deprivation in rats].
Vataev SI; Oganesian GA; Lukomskaia NIa; Magazanik LG
Ross Fiziol Zh Im I M Sechenova; 2013 May; 99(5):575-85. PubMed ID: 24459868
[TBL] [Abstract][Full Text] [Related]
35. [Structure of glutamate receptor ion channels and mechanisms of their blockade by organic cations].
Magazanik LG; Tikhonov DB; Bol'shakov KB; Gmiro VE; Buldakova SL; Samoĭlova MV
Ross Fiziol Zh Im I M Sechenova; 2001 Aug; 87(8):1026-39. PubMed ID: 11601147
[TBL] [Abstract][Full Text] [Related]
36. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
[TBL] [Abstract][Full Text] [Related]
37. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
Schmidt WJ; Bubser M
Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
[TBL] [Abstract][Full Text] [Related]
38. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
López-Gil X; Artigas F; Adell A
Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
[TBL] [Abstract][Full Text] [Related]
39. [Structural characteristics of ionotropic glutamate receptors revealed by channel blockade].
Magazanik LG; Bol'shakov KV; Buldakova SL; Gmiro VE; Dorofeeva NA; Lukomskaia NIa; Potap'eva NN; Samoĭlova MV; Tikhonov DB; Fedorova IM; Frolova EV
Ross Fiziol Zh Im I M Sechenova; 2000 Sep; 86(9):1138-51. PubMed ID: 11081219
[TBL] [Abstract][Full Text] [Related]
40. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
López-Gil X; Babot Z; Amargós-Bosch M; Suñol C; Artigas F; Adell A
Neuropsychopharmacology; 2007 Oct; 32(10):2087-97. PubMed ID: 17356574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
